Latest Mergers And Acquisitions News

Sequoia Financial Group has called off the sale of its InterPrac subsidiary to Conquest Investment Partners, citing unmet conditions and changed circumstances that made completion unviable. The company will now explore alternative strategic paths for InterPrac.

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Contact Energy is set for a leadership shift as Chair Rob McDonald retires after eight transformative years, handing the reins to director Jon Macdonald, whose governance experience promises continuity amid ongoing renewable expansion.

Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.

Electro Optic Systems (ASX: EOS) reported a 13% increase in contract backlog to A$518 million in Q1 2026, driven by multiple major defence orders and the opening of a new Singapore facility. The company’s cash position remains strong despite a $4 million ASIC penalty.

hipages Group has acquired a majority stake in VIZ Insurance, marking its strategic entry into the insurance sector for tradies and broadening its platform offerings.

T&G Global is moving to sell its New Zealand fresh produce and Pacific Island businesses as part of a strategic pivot to concentrate on its premium Apples and VentureFruit platforms. The divestments, pending contract finalisation, mark a significant reshaping of the company’s portfolio amid shareholder shifts.

Anatara Lifesciences delivered ambiguous mechanism of action results for its Anti-Obesity Project while reporting statistically significant weight management effects from compound AOC. The company plans a limited Phase 1 study but may delay it amid ongoing strategic discussions, with cash reserves tightening to $0.7 million.

Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.

Aurum Resources has boosted its total gold resources to 4.2 million ounces across two Côte d’Ivoire projects, supported by ongoing drilling and a strategic placement led by Perseus Mining. The company’s strong cash position and board strengthening set the stage for upcoming feasibility milestones.

Way2VAT reported a 95% surge in Q1 FY26 revenue to $2.05 million, driven by its RBC acquisition and expanding client base, while preparing to launch an e-invoicing platform integrating AI-powered APAI technology.

Predictive Discovery Limited (ASX:PDI) completed its merger with Robex Resources, propelling gold production to 48,178 ounces in Q1 2026 and setting sights on 400,000 ounces annual production by 2029.